These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23819124)

  • 21. Lineage relationship of prostate cancer cell types based on gene expression.
    Pascal LE; Vêncio RZ; Vessella RL; Ware CB; Vêncio EF; Denyer G; Liu AY
    BMC Med Genomics; 2011 May; 4():46. PubMed ID: 21605402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo.
    Gu G; Yuan J; Wills M; Kasper S
    Cancer Res; 2007 May; 67(10):4807-15. PubMed ID: 17510410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cells of Origin for Prostate Cancer.
    Xin L
    Adv Exp Med Biol; 2019; 1210():67-86. PubMed ID: 31900905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostatic inflammation enhances basal-to-luminal differentiation and accelerates initiation of prostate cancer with a basal cell origin.
    Kwon OJ; Zhang L; Ittmann MM; Xin L
    Proc Natl Acad Sci U S A; 2014 Feb; 111(5):E592-600. PubMed ID: 24367088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A plethora of progenitors in the post-natal prostate.
    Goldstein AS; Witte ON
    EMBO Rep; 2012 Dec; 13(12):1036-7. PubMed ID: 23138032
    [No Abstract]   [Full Text] [Related]  

  • 26. Cell differentiation lineage in the prostate.
    Wang Y; Hayward S; Cao M; Thayer K; Cunha G
    Differentiation; 2001 Oct; 68(4-5):270-9. PubMed ID: 11776479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The molecular and cellular origin of human prostate cancer.
    Packer JR; Maitland NJ
    Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1238-60. PubMed ID: 26921821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Local prolactin is a target to prevent expansion of basal/stem cells in prostate tumors.
    Rouet V; Bogorad RL; Kayser C; Kessal K; Genestie C; Bardier A; Grattan DR; Kelder B; Kopchick JJ; Kelly PA; Goffin V
    Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15199-204. PubMed ID: 20699217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate Stem Cells and Cancer Stem Cells.
    Li JJ; Shen MM
    Cold Spring Harb Perspect Med; 2019 Jun; 9(6):. PubMed ID: 30291148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Luminal progenitors restrict their lineage potential during mammary gland development.
    Rodilla V; Dasti A; Huyghe M; Lafkas D; Laurent C; Reyal F; Fre S
    PLoS Biol; 2015 Feb; 13(2):e1002069. PubMed ID: 25688859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal.
    Chiche A; Moumen M; Petit V; Jonkers J; Medina D; Deugnier MA; Faraldo MM; Glukhova MA
    Stem Cells; 2013 Sep; 31(9):1857-67. PubMed ID: 23712598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraepithelial paracrine Hedgehog signaling induces the expansion of ciliated cells that express diverse progenitor cell markers in the basal epithelium of the mouse mammary gland.
    García-Zaragoza E; Pérez-Tavarez R; Ballester A; Lafarga V; Jiménez-Reinoso A; Ramírez A; Murillas R; Gallego MI
    Dev Biol; 2012 Dec; 372(1):28-44. PubMed ID: 23000969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring the origins of the normal prostate and prostate cancer stem cell.
    Kasper S
    Stem Cell Rev; 2008 Sep; 4(3):193-201. PubMed ID: 18563640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate stem cells and prostate cancer.
    Lawson DA; Xin L; Lukacs R; Xu Q; Cheng D; Witte ON
    Cold Spring Harb Symp Quant Biol; 2005; 70():187-96. PubMed ID: 16869753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro propagation and characterization of neoplastic stem/progenitor-like cells from human prostate cancer tissue.
    Guzmán-Ramírez N; Völler M; Wetterwald A; Germann M; Cross NA; Rentsch CA; Schalken J; Thalmann GN; Cecchini MG
    Prostate; 2009 Nov; 69(15):1683-93. PubMed ID: 19644960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Revisiting the concept of cancer stem cells in prostate cancer.
    Wang ZA; Shen MM
    Oncogene; 2011 Mar; 30(11):1261-71. PubMed ID: 21119602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential requirements for β-catenin in murine prostate cancer originating from basal versus luminal cells.
    Lu TL; Chen CM
    J Pathol; 2015 Jul; 236(3):290-301. PubMed ID: 25712462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surface CD24 distinguishes between low differentiated and transit-amplifying cells in the basal layer of human prostate.
    Petkova N; Hennenlotter J; Sobiesiak M; Todenhöfer T; Scharpf M; Stenzl A; Bühring HJ; Schwentner C
    Prostate; 2013 Oct; 73(14):1576-90. PubMed ID: 23836489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of ATF3 promotes hormone-induced prostate carcinogenesis and the emergence of CK5(+)CK8(+) epithelial cells.
    Wang Z; Kim J; Teng Y; Ding HF; Zhang J; Hai T; Cowell JK; Yan C
    Oncogene; 2016 Jul; 35(27):3555-64. PubMed ID: 26522727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Searching for prostate cancer stem cells: markers and methods.
    Sharpe B; Beresford M; Bowen R; Mitchard J; Chalmers AD
    Stem Cell Rev Rep; 2013 Oct; 9(5):721-30. PubMed ID: 23775699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.